title: [Sublingual immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis].
abstract: Specific immunotherapy is the only current treatment that may modify the disease process in allergic rhinoconjunctivitis. Recent studies have evidenced that sublingual administration of grass extract tablets is an efficacious, safe and convenient form of specific immunotherapy in children with grass pollen induced allergic rhinoconjunctivitis. It is recommended that daily treatment is initiated four months before the pollen season begins and continued through three years, though paediatric studies of long-term and potential asthma and allergy prevention effects are still awaited.
authors.affiliation: Børne og Allergi Klinikken, Dytmærsken 9, 8900 Randers, Denmark. akk.odws@dadlnet.dk
authors.forename: Ole D
authors.initials: OD
authors.lastname: Wolthers
authors.forename: Arne
authors.initials: A
authors.lastname: Høst
authors.forename: Birgitte
authors.initials: B
authors.lastname: Frederiksen
authors.forename: Susanne
authors.initials: S
authors.lastname: Halken
mesh_terms: D000286:Administration, Sublingual; D000485:Allergens / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology / Q000494:pharmacology; D002648:Child; D003233:Conjunctivitis, Allergic / Q000276:immunology / Q000628:therapy*; D003888:Desensitization, Immunologic / Q000009:adverse effects / Q000379:methods; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D010936:Plant Extracts / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology / Q000494:pharmacology; D006109:Poaceae / Q000276:immunology; D011058:Pollen / Q000276:immunology; D011788:Quality of Life; D012221:Rhinitis, Allergic, Perennial / Q000276:immunology / Q000628:therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000276:immunology / Q000628:therapy*; D013607:Tablets; D013997:Time Factors
chemical_list: D000485:Allergens; D010936:Plant Extracts; D013607:Tablets; D007073:Immunoglobulin E